Shigeki Hirano

Summary

Affiliation: Chiba University
Country: Japan

Publications

  1. doi request reprint Functional brain imaging of cognitive dysfunction in Parkinson's disease
    Shigeki Hirano
    Department of Neurology, Chiba University School of Medicine, 1 8 1 Inohana, Chuo Ku, Chiba shi, Chiba 260 8670, Japan
    J Neurol Neurosurg Psychiatry 83:963-9. 2012
  2. doi request reprint Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia
    Shigeki Hirano
    Molecular Neuroimaging Group, Molecular Imaging Centre, National Institute of Radiological Sciences, 4 9 1 Anagawa, Inage Ku, Chiba shi, Chiba, 263 8555, Japan
    Brain 133:2058-68. 2010
  3. ncbi request reprint [Network analyses in neuroimaging studies]
    Shigeki Hirano
    Department of Neurology, Graduate School of Medicine, Chiba Univeisity, Japan
    Brain Nerve 65:659-67. 2013
  4. ncbi request reprint [Neuroimaging studies of diabetes and risk of Alzheimer's disease]
    Shigeki Hirano
    Department of Neurology, Graduate School of Medicine, Chiba University, Chuo Ku, China
    Brain Nerve 64:1411-9. 2012
  5. doi request reprint Patterns of sensory nerve conduction abnormalities in Fisher syndrome: more predominant involvement of group Ia afferents than skin afferents
    Yukari Sekiguchi
    Department of Neurology, Graduate School of Medicine, Chiba University, 1 8 1, Inohana, Chuo Ku, Chiba 260 8670, Japan
    Clin Neurophysiol 124:1465-9. 2013
  6. doi request reprint PET study of brain acetylcholinesterase in cerebellar degenerative disorders
    Shigeki Hirano
    Department of Neurology, Chiba University Graduate School of Medicine, Chiba, Japan
    Mov Disord 23:1154-60. 2008

Collaborators

Detail Information

Publications6

  1. doi request reprint Functional brain imaging of cognitive dysfunction in Parkinson's disease
    Shigeki Hirano
    Department of Neurology, Chiba University School of Medicine, 1 8 1 Inohana, Chuo Ku, Chiba shi, Chiba 260 8670, Japan
    J Neurol Neurosurg Psychiatry 83:963-9. 2012
    ....
  2. doi request reprint Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia
    Shigeki Hirano
    Molecular Neuroimaging Group, Molecular Imaging Centre, National Institute of Radiological Sciences, 4 9 1 Anagawa, Inage Ku, Chiba shi, Chiba, 263 8555, Japan
    Brain 133:2058-68. 2010
    ..Significant brain cholinergic deficits were not seen in frontotemporal dementia, which may explain the unresponsiveness of this condition to cholinergic modulation therapy...
  3. ncbi request reprint [Network analyses in neuroimaging studies]
    Shigeki Hirano
    Department of Neurology, Graduate School of Medicine, Chiba Univeisity, Japan
    Brain Nerve 65:659-67. 2013
    ..Future neuroimaging network analysis studies will reveal novel and interesting findings that will uncover the pathomechanisms of neurological and psychiatric disorders...
  4. ncbi request reprint [Neuroimaging studies of diabetes and risk of Alzheimer's disease]
    Shigeki Hirano
    Department of Neurology, Graduate School of Medicine, Chiba University, Chuo Ku, China
    Brain Nerve 64:1411-9. 2012
    ..Studies on the brain of patients with diabetes may provide clues for preventive therapy in AD...
  5. doi request reprint Patterns of sensory nerve conduction abnormalities in Fisher syndrome: more predominant involvement of group Ia afferents than skin afferents
    Yukari Sekiguchi
    Department of Neurology, Graduate School of Medicine, Chiba University, 1 8 1, Inohana, Chuo Ku, Chiba 260 8670, Japan
    Clin Neurophysiol 124:1465-9. 2013
    ..To elucidate the features of sensory nerve involvement in Fisher syndrome (FS), this study extensively investigated sensory electrophysiology...
  6. doi request reprint PET study of brain acetylcholinesterase in cerebellar degenerative disorders
    Shigeki Hirano
    Department of Neurology, Chiba University Graduate School of Medicine, Chiba, Japan
    Mov Disord 23:1154-60. 2008
    ..Reduction of AChE activities in the thalamus and cerebellum in MSA and in the thalamus in SCA-3 suggest that cholinergic modulating drugs may have a role in the treatment of ataxia and other symptoms in these disorders...